Wuhan Keqian Biology Co.,Ltd
SSE:688526.SS
17 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 381.49 | 395.935 | 409.147 | 570.636 | 447.803 | 242.642 | 388.913 | 320.312 | 186.168 |
| Depreciation & Amortization
| 109.5 | 114.496 | 97.687 | 62.643 | 37.029 | 37.148 | 34.704 | 23.442 | 19.164 |
| Deferred Income Tax
| 0 | 0 | 16.64 | 16.162 | -0.298 | 2.947 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -43.959 | -13.255 | -64.32 | -63.291 | -61.071 | -101.226 | -49.414 | -2.513 | 15.588 |
| Accounts Receivables
| -20.402 | -19.848 | -134.358 | -118.72 | -123.294 | -53.236 | -38.608 | -51.733 | 0 |
| Inventory
| 6.431 | 8.808 | -67.962 | -38.499 | -10.026 | 7.078 | -11.885 | -31.443 | -3.467 |
| Accounts Payables
| 0 | 15.154 | 121.36 | 77.766 | 72.546 | -58.014 | 0 | 0 | 0 |
| Other Working Capital
| -29.987 | -17.369 | 16.64 | 16.162 | -0.298 | 2.947 | -37.529 | 28.93 | 19.055 |
| Other Non Cash Items
| -54.349 | 40.858 | -18.805 | -38.718 | -23.624 | -23.677 | -22.368 | -3.629 | -0.227 |
| Operating Cash Flow
| 392.682 | 538.034 | 423.709 | 531.27 | 400.137 | 154.888 | 351.835 | 337.612 | 220.693 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -106.944 | -104.504 | -102.851 | -374.446 | -111.596 | -137.736 | -31.421 | -129.114 | -29.13 |
| Acquisitions Net
| 0 | -4.05 | -8.461 | 0.545 | 111.626 | 137.736 | -0 | 129.114 | 29.133 |
| Purchases Of Investments
| -1,172.849 | -2,264.308 | -1,439.75 | -1,113 | -1,783.4 | -1,261.05 | -1,207 | -807 | -90 |
| Sales Maturities Of Investments
| 1,373.789 | 1,982.862 | 913.85 | 1,156.345 | 704.67 | 775.063 | 1,549.769 | 436.449 | 121.921 |
| Other Investing Activites
| 2.59 | 61.004 | 0.084 | -0.545 | -111.596 | -137.736 | 11.683 | -129.114 | -29.13 |
| Investing Cash Flow
| 96.587 | -328.996 | -637.127 | -331.1 | -1,190.296 | -623.723 | 323.031 | -499.665 | 2.795 |
| Financing Activities: | |||||||||
| Debt Repayment
| -286.49 | 14.99 | 193.51 | 17.99 | 60 | 0 | 0 | 0 | -4 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -204.581 | -97.086 | -88.375 | -134.85 | -0.369 | -85.752 | -122.28 | -47.245 | -30.024 |
| Other Financing Activities
| -12.106 | -20.33 | 8.39 | -4.322 | 1,146.093 | 0 | 1.562 | -2.55 | -0.006 |
| Financing Cash Flow
| -503.177 | -102.425 | 113.525 | -121.182 | 1,205.724 | -85.752 | -120.717 | -49.795 | -34.03 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0.018 | 0.055 | 0 | -0 | -0 | 0 | 0 | -0 | 0 |
| Net Change In Cash
| -13.89 | 106.667 | -99.894 | 78.988 | 415.565 | -554.587 | 554.149 | -211.848 | 189.457 |
| Cash At End Of Period
| 543.479 | 557.369 | 450.701 | 550.596 | 471.608 | 56.043 | 610.63 | 56.481 | 268.329 |